WO2016083990A1 - Method of sanitizing microbiological environment - Google Patents

Method of sanitizing microbiological environment Download PDF

Info

Publication number
WO2016083990A1
WO2016083990A1 PCT/IB2015/059070 IB2015059070W WO2016083990A1 WO 2016083990 A1 WO2016083990 A1 WO 2016083990A1 IB 2015059070 W IB2015059070 W IB 2015059070W WO 2016083990 A1 WO2016083990 A1 WO 2016083990A1
Authority
WO
WIPO (PCT)
Prior art keywords
environment
bacteria
biocontrol
microorganisms
pathogens
Prior art date
Application number
PCT/IB2015/059070
Other languages
French (fr)
Inventor
Marek JAMROZY
Original Assignee
Jamrozy Marek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jamrozy Marek filed Critical Jamrozy Marek
Publication of WO2016083990A1 publication Critical patent/WO2016083990A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/25Paenibacillus
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20Bacteria; Substances produced thereby or obtained therefrom
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/28Streptomyces
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00Specific treatment goals
    • C02F2303/04Disinfection

Definitions

  • the main idea of invention is a method of sanitization of microbiological environment, which can be accomplished by modification of microbiologic environment. This aim is achieved by application of specially selected bacteria, fungi or other microorganisms, which are able to produce their own metabolites. This way enables to reduce or completely eliminates diseases caused by microorganisms found in human and animal habitats.
  • sanitization is defined as the reduction of pathogenic organisms number to the level at which they do not pose a disease threat to their hosts and without any negative impact on products produced for customer. It is very crucial that sanitization has to be neutral for macro - environment.
  • bacteriaphages During sanitization process, the natural abilities of bacteriaphages are used. They infect bacteria and cause cell lysis. It is essential to identify an etiologic factor of infection before induction of bacteriophage and choose the suitable strain of bacteriophage characterized with the highest lysis potential towards specified bacterium strain. Typically, phages affect on one kind of bacterium, so they are multiplied only within one species of bacterium or its strain. However, sanitizers containing bacteria and fungi are able to act on wider spectrum disease-causing bacteria and fungi. Treatment with highly specified phages can be troublesome owing to the fact of necessity of extraction infectious bacterium.
  • antibiotic microorganisms presented in invention, possess wide range of activity towards harmful microbes.
  • Phages application also requires taking into account that phages encode genes of toxicity, as a consequence, transform harmless bacteria into pathogens.
  • phages encode genes of toxicity, as a consequence, transform harmless bacteria into pathogens.
  • the solution is lack of using lysogenic phages or precisely known phages with vector ones incapable to replication.
  • lizogenia is undoubtedly dangerous side reaction and current scientific knowledge does not present the way of prevention. Phages are also characterized by expanding only in the presence of targeted species. When targeted species disappear from environment, their phages as well die out. Reappearance in environment pathogenic microbes requires introducing specific bacteriophages. It is very difficult to control and catch a moment when specified bacteriophages have to be necessarily introduced.
  • the method according to invention refers to other kind of microorganisms: bacteria, fungi and other microorganisms, which are able to form their own metabolites. Bacteria have wider spectrum of antibiotic properties towards other pathogenic species. As a pattern, strains of bacteria used in presented invention, successfully fight listed species: Pseudomonas aeruginosa, Salmonella typhimurium, Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Sarcina lutea, Streptococcus pneumonia, Streptococcus agalactiae, Streptococcus faecalis, Streptococcus mutant, Escherichia coli, Candida albicans, what was proved in research which was checked towards bacteria strains mentioned before.
  • efficacy 100% and it is followed by completely elimination of pathogens.
  • Such effectiveness is gained towards for example: E.coli, S. aureus, Candidia sp., S. agalactie and A. baumann.
  • the range of efficient activity, presented in invention is wider than in commonly known action of phages. It is worth emphasizing, the preventing action of existing in environment bacteria, even in spite of lack of pathogens. Antibiotic bacteria still remain in environment, ready to action in case of renew appearing pathogens.
  • the invention gives an opportunity to enter into environment bacteria metabolites working against pathogens, instead of pure bacteria. In that moment, the protection is active only when there is sufficient amount of antibiotic compounds.
  • Presented invention assumes, sanitization of microbiological environment with selected and specially prepared microorganisms or their metabolites by modification of environment, using antibiotic properties of them. As a result, pathogens are reduced or completely removed from environment through application of single or mixture strains of bacteria or their metabolites.
  • bacteria, fungi, actinomycetes and other extracted from natural environment were analyzed and their influence on commonly found pathogens among humans and animals.
  • influence on such a common pathogens Escherichia coli, Staphylococcus aureus, streptococcus and salmonella were tested.
  • strains are tended to show tolerance for common microorganisms found in environment and remain neutral to health of people and animals. This fact means that bacteria strains work against harmful microbes and simultaneously modify microbial environment into health desired direction. Thus, the sanitation effect is gained by reduction or complete elimination of disease causing pathogenes. As a result of this elimination, the number of diseases caused by microbes living in environment is reduced.
  • the subject of invention is method of sanitization of microbiological environment of people and animals. It is achieved by modification of microbiological environment, in which at first, one or more pathogenic factors are identified, then suitable mean of biocontrol is adjusted by using specially selected microorganisms that are capable to produce their own metabolites, and finally selected microorganisms are introduced into environment. So, the primary feature of invention is opportunity to introduce metabolites instead of microorganisms. In that moment, protection acts, only if there is sufficient amount of antibiotic compounds in environment.
  • Preferable and additional advantage of presented invention is an opportunity of introducing mean of biocontrol in different forms. It is implemented by: large or small droplet sprays, cold misting or powder and it covers surfaces giving the best contact with fought strains.
  • Identification of pathogenic factor is primarily based on well known pathogenic agents. If standard treatment does not give positive effect, more accurate analysis and identification of infectious microbes may be necessary and investigation of antibiotic effectiveness strains which fight with disease in particular environment.
  • the number of antibiotic strains proceeds by checking of antibiotic effectiveness bacteria used for sanitization of environment.
  • the number of cells which are fought, and the number of antibiotic cells, are checked on petrie dishes. As a result, needful measure of antibiotic bacteria is determined and introduced to environment.
  • the other invention quality is possibility to apply it in whole farm buildings and their side area.
  • the moment of application the mean of biocontrol is adjusted to successful effect of modification.
  • Microorganisms used to fight against pathogens belong to low-risk microorganisms.
  • Action of invention is submitted in pattern of mastitis among milking cows. In most important cases, infectious problems caused by environmental microflora are examined and pathogenic organisms are known. However, in every even well-maintained herd, some difficulties may occur.
  • the pathogenic microbes mostly responsible (90%) for mastitis, are: Ataphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae and Staphylococcus uberis.
  • mastitis Staphylococcus epidermis, Clostriduym perfmgens, Corynebacterium pygogenes, Escherichia coli, Klebsiella spp, Candida albicans or Mycoplasma spp.
  • the amount of vaccine is calculated and introduced to microbiological environment through small droplets spray.
  • the presented invention is also concerned to other diseases and their pathogens: infectious atrophic rhinitis Pasteurella multocida an d Bordetella bronchiseptica), streptococci s,

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention presents method of sanitization of microbiological environment surrounding people and animals. It relies on modification of environment by identification one or more pathogenes, choosing the way of biocontrol through previously selected bacteria strains, fungi or other microorganisms, able to produce own metabolites. Their action is checked and then, they are introduced to environment.

Description

Method of sanitization of microbiological environment
The main idea of invention is a method of sanitization of microbiological environment, which can be accomplished by modification of microbiologic environment. This aim is achieved by application of specially selected bacteria, fungi or other microorganisms, which are able to produce their own metabolites. This way enables to reduce or completely eliminates diseases caused by microorganisms found in human and animal habitats.
It is common fact that disease - causing organisms like bacteria, fungi, viruses and other are occurred in microbiological environment of people and animals. They are very important in livestock production and influence on farmers' profit. It is estimated that losses connected with single treatment of mastitis amount 1000 - 1200 PLN. This sum could be multiplied in case of repeated action. Moreover, sick cows might be scrapped of herds. Other diseases, mostly found among young animals, do not allow them to reach the highest possible potential of production.
There are some available methods, which are intended to decrease level of microorganisms in microbiological environment. Each of them has advantages and drawbacks depended on different factors. However, the best way of prevention is contamination avoidance. Therefore, sanitization is defined as the reduction of pathogenic organisms number to the level at which they do not pose a disease threat to their hosts and without any negative impact on products produced for customer. It is very crucial that sanitization has to be neutral for macro - environment.
As standard, two main methods of sanitization are used: chemical (detergents, chlorine, hypochlorite, ozone) and physical (rinsing, temperature, high pressure, electric and magnetic field, ultrasounds or UV radiation). Both methods give short-term and selective effect to proper modification of microbiological environment. Frequently, after their application in microenvironment, appears other adverse pathogenic microorganisms like fungi, causing additional health problems. Furthermore, wide range of antibiotics used in treatment results in increasing resistance of disease- causing organisms, and finally, encourage researchers to find new ways of reaction.
In sanitation process, some means of biocontrol are applied. Presented invention is concerned in these categories. Currently, bacteriophages are used as a mean of biocontrol in sanitization. American patent description US2004191224 reveals sanitization method which relies on microbiological modification by spraying previously cleaned surface with large droplet washing containing one or more bacteriophages, as a mean of biocontrol. This way of action is expensive and trouble-some due to high costs of bacteriophage's multiplication. Much more effective and easier in usage in industrial scale is presented invention, which assumes using bacteria or their metabolites as a method of biocontrol. Bacteria are multiplied easily at and at little cost.
During sanitization process, the natural abilities of bacteriaphages are used. They infect bacteria and cause cell lysis. It is essential to identify an etiologic factor of infection before induction of bacteriophage and choose the suitable strain of bacteriophage characterized with the highest lysis potential towards specified bacterium strain. Typically, phages affect on one kind of bacterium, so they are multiplied only within one species of bacterium or its strain. However, sanitizers containing bacteria and fungi are able to act on wider spectrum disease-causing bacteria and fungi. Treatment with highly specified phages can be troublesome owing to the fact of necessity of extraction infectious bacterium. On the contrary, antibiotic microorganisms, presented in invention, possess wide range of activity towards harmful microbes. Phages application also requires taking into account that phages encode genes of toxicity, as a consequence, transform harmless bacteria into pathogens. Despite of the fact that the newest research enable to isolate toxic genes, still all the virulence factors are not well known. The solution is lack of using lysogenic phages or precisely known phages with vector ones incapable to replication.
Usage of phages also needs consideration of negative lizogenia process, relies on bacteria immunization on phages. In case of acquired resistance, lysogenic cycle in bacterium is not proceeded, and virus is halted to pre-phage stadium. This process is frequently connected with bacterium adjustment and leads to higher virulence. Thus, lizogenia is undoubtedly dangerous side reaction and current scientific knowledge does not present the way of prevention. Phages are also characterized by expanding only in the presence of targeted species. When targeted species disappear from environment, their phages as well die out. Reappearance in environment pathogenic microbes requires introducing specific bacteriophages. It is very difficult to control and catch a moment when specified bacteriophages have to be necessarily introduced. If it is failed, and the infection symptoms occur again, the results for humans and animals could be dangerous. The other point is some number of disease asymptomatic carriers. For instance, it has been found that amount of carriers Staphylococcus aureus in human population is estimated from 10 to 40%. Thus, for protective existence of phage, living in fought bacterium environment is needed. Therefore, in case of host disappearing, bacteriophage does not have successful effectiveness and ensure reduction of microbial threat.
The method according to invention refers to other kind of microorganisms: bacteria, fungi and other microorganisms, which are able to form their own metabolites. Bacteria have wider spectrum of antibiotic properties towards other pathogenic species. As a pattern, strains of bacteria used in presented invention, successfully fight listed species: Pseudomonas aeruginosa, Salmonella typhimurium, Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Sarcina lutea, Streptococcus pneumonia, Streptococcus agalactiae, Streptococcus faecalis, Streptococcus mutant, Escherichia coli, Candida albicans, what was proved in research which was checked towards bacteria strains mentioned before. In case of some pathogenic microbes remarked before, efficacy equals 100% and it is followed by completely elimination of pathogens. Such effectiveness is gained towards for example: E.coli, S. aureus, Candidia sp., S. agalactie and A. baumann. The range of efficient activity, presented in invention, is wider than in commonly known action of phages. It is worth emphasizing, the preventing action of existing in environment bacteria, even in spite of lack of pathogens. Antibiotic bacteria still remain in environment, ready to action in case of renew appearing pathogens. The invention gives an opportunity to enter into environment bacteria metabolites working against pathogens, instead of pure bacteria. In that moment, the protection is active only when there is sufficient amount of antibiotic compounds.
Presented invention assumes, sanitization of microbiological environment with selected and specially prepared microorganisms or their metabolites by modification of environment, using antibiotic properties of them. As a result, pathogens are reduced or completely removed from environment through application of single or mixture strains of bacteria or their metabolites.
During developing of invention and examining various microorganisms: bacteria, fungi, actinomycetes and other extracted from natural environment, their mutual reactions were analyzed and their influence on commonly found pathogens among humans and animals. In this research, influence on such a common pathogens: Escherichia coli, Staphylococcus aureus, streptococcus and salmonella were tested. Studies were made on referencial pathogenic species. They proved that possessed strains are highly effective towards widespread pathogens, encountered in animals and humans.
At the same time, previously mentioned strains are tended to show tolerance for common microorganisms found in environment and remain neutral to health of people and animals. This fact means that bacteria strains work against harmful microbes and simultaneously modify microbial environment into health desired direction. Thus, the sanitation effect is gained by reduction or complete elimination of disease causing pathogenes. As a result of this elimination, the number of diseases caused by microbes living in environment is reduced.
In each environment, surrounding people and animals, has very specific microflora and different from other. In some cases, the source of infections are well known and kinds of microorganisms responsible for certain diseases. Such a situation occurs in previously remarked mastitis, found in dairy cattle. Other diseases commonly happened among livestock are also examined and their reasons, too. In animal surround, still lots of health neutral microorganisms exist and do not let other harmful ones to multiply: for instance fungi. Excluding pathogens, other microbial organisms maintain in stable balance. So far, the methods of complete environment modification in farm buildings, relied on replacing pathogenic organisms with their natural foes (neutral for animals), have not been known.
The subject of invention is method of sanitization of microbiological environment of people and animals. It is achieved by modification of microbiological environment, in which at first, one or more pathogenic factors are identified, then suitable mean of biocontrol is adjusted by using specially selected microorganisms that are capable to produce their own metabolites, and finally selected microorganisms are introduced into environment. So, the primary feature of invention is opportunity to introduce metabolites instead of microorganisms. In that moment, protection acts, only if there is sufficient amount of antibiotic compounds in environment. Preferable and additional advantage of presented invention is an opportunity of introducing mean of biocontrol in different forms. It is implemented by: large or small droplet sprays, cold misting or powder and it covers surfaces giving the best contact with fought strains.
Identification of pathogenic factor is primarily based on well known pathogenic agents. If standard treatment does not give positive effect, more accurate analysis and identification of infectious microbes may be necessary and investigation of antibiotic effectiveness strains which fight with disease in particular environment.
In other cases, when infectious factors are still unknown, further research is needed. In order to find the source of infection, matching of antibiotic strains with identified pathogens is gradually checked.
The number of antibiotic strains (density of vaccine) proceeds by checking of antibiotic effectiveness bacteria used for sanitization of environment. The number of cells which are fought, and the number of antibiotic cells, are checked on petrie dishes. As a result, needful measure of antibiotic bacteria is determined and introduced to environment.
The other invention quality is possibility to apply it in whole farm buildings and their side area. The moment of application the mean of biocontrol is adjusted to successful effect of modification. Microorganisms used to fight against pathogens belong to low-risk microorganisms. Action of invention is submitted in pattern of mastitis among milking cows. In most important cases, infectious problems caused by environmental microflora are examined and pathogenic organisms are known. However, in every even well-maintained herd, some difficulties may occur. The pathogenic microbes, mostly responsible (90%) for mastitis, are: Ataphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae and Staphylococcus uberis. The other reasons of mastitis are: Staphylococcus epidermis, Clostriduym perfmgens, Corynebacterium pygogenes, Escherichia coli, Klebsiella spp, Candida albicans or Mycoplasma spp.
Knowing this knowledge, some selected species of microorganisms are matched i.e. Ochrobacterum, Paenibacillus, Streptomyces, Humicola and others in single strain form or mixture of strains. Then, the action of selected bacterium strains are checked on petrie dishes. That kind of verification also tests the lack of negative influence on humans and animals health, which is vital condition of introducing to environment. This verification is gradually conducted, beginning from simple organisms to vertebratas. Checking antibiotic activity of chosen strains is proceeded not only towards pathogens, occurred in contaminated buildings, but also on referential strains. This kind of procedure guarantees high effectiveness of pathogens overpowering.
Knowing the number of fought pathogens and fighting against them antibiotic bacteria (checked in petrie dishes), the amount of vaccine is calculated and introduced to microbiological environment through small droplets spray.
If applied treatment does not give satisfactory effect more detailed identification of pathogenic microbes existing in certain environment is needed.
The presented invention is also concerned to other diseases and their pathogens: infectious atrophic rhinitis Pasteurella multocida an d Bordetella bronchiseptica), streptococci s,
Glasser's disease {Haemophilus parasuis), diseases caused by anaerobic bacteria(C I os iridium perfringes) , c o c ci di o s i s , exudative dermatitis {Staphylococcus hyicus), colibacilosis, salmonellosis, hyperplasia (Lawsonia (L) intracellular is) , dysentery Serpulina), MMA, paratuberculosis, and for poultry diseases like salmonellosis, streptococci s, colibacilosis or diseases caused by anaerobic bacteria.

Claims

Claims
Method of sanitization of microbiological environment surrounding people or animals which relies on modification of environment by identification of one or more pathogenes, choosing the way of biocontrol mean, which action is checked and then, the mean of biocontrol is introduced to environment characterized in that the mean of biocontrol, introduced in certain quantity, consists of selected strains of bacteria, fungi and other microorganisms which are able to produce their own metabolites.
Method according to claim 1, characterized in that introduction of biocontrol mean relies on small or large droplet, cold misting or introduction by powder.
Method according to claim 1 or 2, characterized in that identification of pathogenic factor is based on identification pathogens in definite environment.
4. Method according to claim 1 or 2, characterized in that after identification of pathogenic factor, antibiotic effectiveness is checked.
PCT/IB2015/059070 2014-11-25 2015-11-24 Method of sanitizing microbiological environment WO2016083990A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PLP.410247 2014-11-25
PL410247A PL410247A1 (en) 2014-11-25 2014-11-25 Method for sanitization of the microbiological surroundings

Publications (1)

Publication Number Publication Date
WO2016083990A1 true WO2016083990A1 (en) 2016-06-02

Family

ID=55085690

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/059070 WO2016083990A1 (en) 2014-11-25 2015-11-24 Method of sanitizing microbiological environment

Country Status (2)

Country Link
PL (1) PL410247A1 (en)
WO (1) WO2016083990A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159540A (en) * 1962-07-03 1964-12-01 Bristol Banyu Res Inst Ltd Antibiotic cirramycin and its production
EP0100605A1 (en) * 1982-07-30 1984-02-15 Eli Lilly And Company A47934 antibiotic and its production
US6264967B1 (en) * 1999-07-14 2001-07-24 Shinei Fermentec Corporation Method for eliminating Staphylococcus aureus, novel microorganism of genus Brachybacterium, and care garment, care sheet or care bedclothes, each being immobilized with microorganism of genus Brachybacterium
EP1312371A1 (en) * 2000-08-10 2003-05-21 Shinei Fermentec Corporation Animal papilla disinfectants and method of improving microbial environment
US20040191224A1 (en) 2000-01-11 2004-09-30 Intralytix, Inc. Method and device for sanitation using bacteriophages

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159540A (en) * 1962-07-03 1964-12-01 Bristol Banyu Res Inst Ltd Antibiotic cirramycin and its production
EP0100605A1 (en) * 1982-07-30 1984-02-15 Eli Lilly And Company A47934 antibiotic and its production
US6264967B1 (en) * 1999-07-14 2001-07-24 Shinei Fermentec Corporation Method for eliminating Staphylococcus aureus, novel microorganism of genus Brachybacterium, and care garment, care sheet or care bedclothes, each being immobilized with microorganism of genus Brachybacterium
US20040191224A1 (en) 2000-01-11 2004-09-30 Intralytix, Inc. Method and device for sanitation using bacteriophages
EP1312371A1 (en) * 2000-08-10 2003-05-21 Shinei Fermentec Corporation Animal papilla disinfectants and method of improving microbial environment

Also Published As

Publication number Publication date
PL410247A1 (en) 2016-06-06

Similar Documents

Publication Publication Date Title
Rodrigues et al. Listeria monocytogenes and Salmonella enterica Enteritidis biofilms susceptibility to different disinfectants and stress-response and virulence gene expression of surviving cells
Cerf et al. Tests for determining in-use concentrations of antibiotics and disinfectants are based on entirely different concepts:“Resistance” has different meanings
Humayoun et al. An assay for determining the susceptibility of Salmonella isolates to commercial and household biocides
Stringfellow et al. Evaluation of disinfectants commonly used by the commercial poultry industry under simulated field conditions
Obe et al. Prevalence of Salmonella enterica on poultry processing equipment after completion of sanitization procedures
Gunaydin et al. In vitro antimicrobial activity of Medilox® super-oxidized water
Wales et al. Disinfectant testing for veterinary and agricultural applications: A review
Kawai et al. Control of Pseudomonas mastitis on a large dairy farm by using slightly acidic electrolyzed water
Iñiguez-Moreno et al. Antimicrobial activity of disinfectants commonly used in the food industry in Mexico
Skowron et al. Comparison of the effectiveness of dipping agents on bacteria causing mastitis in cattle
Kabir et al. Prevalence and molecular detection of the causal agents of sub-clinical mastitis in dairy cows in Sirajganj and Pabna districts, Bangladesh.
Aksoy et al. Comparative evaluation of the effects of binzalkonium chloride, iodine, gluteraldehyde and hydrogen peroxide disinfectants against avian Salmonellae focusing on genotypic resistance pattern of the Salmonellae serotypes toward benzalkonium chloride
Wang et al. In vitro evaluation of six chemical agents on smooth Brucella melitensis strain
Martykanova et al. Skin microbiota in contact sports athletes and selection of antiseptics for professional hygiene
KR101567670B1 (en) a method for the bacterial inactivation By combined treatment of caprylic acid and citric acid, and predictive model method
Kotb et al. Sensitivity of methicillin-resistance and methicillin-susceptible Staphylococcus aureus strains to some different disinfectants.
Yanik et al. An ınvestigation into the in-vitro effectiveness of electrolyzed water against various microorganisms
WO2016083990A1 (en) Method of sanitizing microbiological environment
Gong et al. Application of bacteriophages to reduce Salmonella contamination on workers’ boots in rendering-processing environment
El-Gohary et al. In-Vitro Investigation on the Antiseptic Efficacy of Commonly Used Disinfectants in Dairy Farms Against Methicillin-Resistant Staphylococcus Aureus.
Shaqra et al. Susceptibility of some bacterial contaminants recovered from commercial cosmetics in Jordan to preservatives and antibiotics
Wood et al. Effectiveness of a steam cleaning unit for disinfection in a veterinary hospital
El-Mahallawy et al. Zoonotic Importance of Some Pathogenic Bacteria Isolated from Small Ruminants' Milk and Hands of Dairy Workers
Obi et al. Antimicrobial activities of some household Disinfectants on selected human pathogens in Umuahia, Abia state, Nigeria
Futoma-Kołoch et al. The risk of Salmonella resistance following exposure to common disinfectants: an emerging problem

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15823381

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 27.09.2017)

122 Ep: pct application non-entry in european phase

Ref document number: 15823381

Country of ref document: EP

Kind code of ref document: A1